Arch Biopartners Market Cap

Arch Biopartners has a market cap or net worth of $79.75 million as of May 13, 2025. Its market cap has decreased by -28.21% in one year.

Market Cap

79.75M

Enterprise Value

81.99M

Revenue

1.35M

Ranking

n/a

PE Ratio

n/a

Stock Price

$1.21

Market Cap Chart

Since January 21, 2011, Arch Biopartners's market cap has increased from 33.63M to 79.75M, an increase of 137.16%. That is a compound annual growth rate of 6.22%.

Market Cap History

Date	Market Cap	% Change
May 12, 2025	79.75M	-9.04%
Dec 31, 2024	87.67M	25.12%
Dec 29, 2023	70.07M	-46.02%
Dec 30, 2022	129.79M	-23.83%
Dec 31, 2021	170.40M	148.54%
Dec 29, 2020	68.56M	57.72%
Dec 26, 2019	Pro	Pro
Dec 26, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 16, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	1.64B
Nika Pharmaceuticals	1.02B
Veradigm	712.65M
Tian'an Technology Group	591.73M
Glass House Brands	478.11M
CytoDyn	475.96M
Elite Pharmaceuticals	468.54M
Northwest Biotherapeutics	413.23M

Market Cap Rankings